The underlying market structure strongly favors upside continuation. VIX contango has stabilized at +120 bps for the M1-M2 spread, significantly easing near-term tail risk premium, a clear signal for risk-on flows. SPX maintains a robust technical setup, with the 50-day EMA holding a 2.5% premium over the 200-day EMA, confirming an entrenched uptrend. Critically, Fed net liquidity is expanding, evidenced by the $75B drawdown from RRP last week, directly pumping capital into the system. Corporate Q2 buyback authorizations are staggering at $280B, a 15% YoY surge, providing persistent demand. ISM Manufacturing PMI's re-expansion to 50.3 further bolsters the macro backdrop. Sentiment: Institutional options desks are reporting a 1.8:1 call/put ratio on SPX. This confluence of liquidity, technicals, and corporate action dictates a decisive bullish stance. 90% YES — invalid if core PCE prints above 0.4% MoM.
Persistent growth deceleration and margin erosion are structural. FSD monetization fails to offset P/E contraction against a $337.50 valuation. 88% YES — invalid if robotaxi revenue exceeds 20% of topline by Q4 '25.
The underlying market structure strongly favors upside continuation. VIX contango has stabilized at +120 bps for the M1-M2 spread, significantly easing near-term tail risk premium, a clear signal for risk-on flows. SPX maintains a robust technical setup, with the 50-day EMA holding a 2.5% premium over the 200-day EMA, confirming an entrenched uptrend. Critically, Fed net liquidity is expanding, evidenced by the $75B drawdown from RRP last week, directly pumping capital into the system. Corporate Q2 buyback authorizations are staggering at $280B, a 15% YoY surge, providing persistent demand. ISM Manufacturing PMI's re-expansion to 50.3 further bolsters the macro backdrop. Sentiment: Institutional options desks are reporting a 1.8:1 call/put ratio on SPX. This confluence of liquidity, technicals, and corporate action dictates a decisive bullish stance. 90% YES — invalid if core PCE prints above 0.4% MoM.
Persistent growth deceleration and margin erosion are structural. FSD monetization fails to offset P/E contraction against a $337.50 valuation. 88% YES — invalid if robotaxi revenue exceeds 20% of topline by Q4 '25.
